# Sipra reviews (2026): GLP-1 telehealth sellers | This GLP Sipra publishes the ingredients and formats in its compounded weight-loss range and describes ongoing side-effect support. Publisher: This GLP Editorial Team Canonical: https://thisglp.com/reviews/sipra Updated: 2026-10-28 By [This GLP Editorial Team](https://thisglp.com/about) · Updated October 2026 Injection additives and oral formats disclosed # Sipra review Sipra publishes the ingredients and formats in its compounded weight-loss range and describes ongoing side-effect support. ## The verdict Sipra explains its formulations and ongoing support more clearly than a single generic GLP-1 label, while individual follow-up details still need confirming. **Disclosure:** This GLP is reader-supported. Some links below are affiliate links — if you start care through them we may earn a commission, at no extra cost to you. The order on this page is not commercial, and a commission never changes what we write about a provider. [How we make money](https://thisglp.com/disclosures). Category GLP-1 telehealth Molecule Semaglutide · Tirzepatide Form Injection · Oral Prescription Required Compounded Yes — not FDA-approved Sipra is an online platform offering compounded weight-management prescriptions alongside other care categories. Its weight-loss page names semaglutide and tirzepatide injections and dissolving oral products. 1. ## Who writes the prescription, and what do they see? A licensed U.S. physician reviews the online information and decides whether to prescribe. The platform describes physician visits and follow-ups, but the treating clinician and specific dispensing pharmacy need confirming for an individual order. Sipra describes regular check-ins, on-demand medical support, help with side effects and dose adjustments. It does not establish a fixed appointment frequency for every patient. Ask how the monitoring plan changes once a dose is stable. 2. ## What happens when the dose goes up? Doses are adjusted as treatment progresses under the clinician’s direction. Oral and injected preparations should not share an assumed dose schedule. Establish which symptoms warrant contacting the provider before the next shipment. 3. ## What the price includes The page lists different starting figures for injections and oral preparations. Those labels do not establish the selected ongoing plan total. Cancellation is online, but Sipra says canceling does not stop an order already sent to the pharmacy. 4. ## What it claims, and what it cites The injection listings include B12, while the [semaglutide](https://thisglp.com/research/semaglutide-cochrane-review) oral listing includes B6. The compounded treatments are not FDA-approved. Confirm the actual ingredient combination and route rather than comparing all formats as the same medicine. ## Where it holds up, and where it does not - Strength: Injection additives and oral formats disclosed - Strength: Provider follow-ups and side-effect support described - Strength: Online cancellation is available - Limitation: Starting figures are not a complete ongoing quote - Limitation: Assigned pharmacy needs confirming - Limitation: Pharmacy orders cannot simply be reversed by canceling ## What the evidence says about this kind of treatment The assessment above is about Sipra. These are about the drugs it sells, and they are traced to the primary literature. - [What happens to the dose, and to the side effects, over the first twenty weeks?](https://thisglp.com/research/how-long-does-nausea-last-on-a-glp1) - [How much of the weight lost is muscle, and what changes that?](https://thisglp.com/research/muscle-loss-on-glp1) - [What does the trial evidence show when treatment stops?](https://thisglp.com/research/stopping-glp1-and-weight-regain) Right for Someone who wants a provider-guided comparison of compounded formats and can clarify the monitoring plan. Wrong for Someone who expects an account cancellation to reverse a prescription already sent to the pharmacy. ## The evidence behind what Sipra prescribes These studies examine the medicines, not this provider. Results with approved products do not establish the quality or effectiveness of a seller’s compounded formulation. - [Cochrane Review of Semaglutide for Obesity: 18 Trials Graded](https://thisglp.com/research/semaglutide-cochrane-review) A 2025 Cochrane review pooled eighteen randomized trials. The weight figure is high certainty and smaller than the marketing, and almost everything else is graded lower. - [Tirzepatide vs Semaglutide: Which Works Better for Weight Loss?](https://thisglp.com/research/tirzepatide-vs-semaglutide-which-works-better) In a 72-week randomized trial at weight-management doses, weight fell 20.2 percent on tirzepatide and 13.7 percent on semaglutide. Routine-care studies found a smaller gap, three to four points. ## How Sipra compares | Seller | Who it suits | Go | | --- | --- | --- | | SkinnyRx | Readers choosing tirzepatide, the one line with a published standing rate | | | ShedRx | Readers willing to telephone a seller and ask which published fee is the real one | | | RxSpan MD | Buyers who want the standing rate, the pharmacy and the prescriber named before signing up | | [Compare all providers side by side →](https://thisglp.com/best) More GLP-1 telehealth sellers reviews: [Trimi Health](https://thisglp.com/reviews/trimi-health) [TrimRx](https://thisglp.com/reviews/trimrx) [Trinity Meds](https://thisglp.com/reviews/trinity-meds) [TRT Nation](https://thisglp.com/reviews/trt-nation) [Tru2u](https://thisglp.com/reviews/tru2u) [TrueMe](https://thisglp.com/reviews/trueme) Sponsored alternative SkinnyRx Readers choosing tirzepatide, the one line with a published standing rate ## Frequently asked What should I confirm about ongoing care? Sipra describes regular check-ins, on-demand medical support, help with side effects and dose adjustments. It does not establish a fixed appointment frequency for every patient. Ask how the monitoring plan changes once a dose is stable. Ask who makes clinical decisions between refills and how to reach that person. Is a prescription guaranteed? No. An independent licensed clinician must decide whether treatment is appropriate; a product page or completed intake does not establish eligibility. ## Sources for this review Provider information checked October 26, 2026. Terms can change. - [Weight-loss care, formats and billing](https://www.sipra.com/weight-loss) - [Semaglutide program](https://www.sipra.com/medications/semaglutide) Or [compare every seller we cover](https://thisglp.com/best). **Research, not medical advice.** This GLP is independent and educational. Nothing here is a substitute for individualized care from a licensed clinician, and reading it creates no doctor–patient relationship. Talk to your own provider before starting, stopping, or changing any medication, peptide, or therapy. See our [methodology](https://thisglp.com/methodology) and [terms](https://thisglp.com/terms).